Teva: It’s Never Too Late to Sell

It was just two months ago that Teva Pharmaceutical Industries (TEVA) hired Kare Schultz as its new CEO, ending months of speculation about who would be tasked to steer the troubled specialty drug maker. Teva Pharmaceutical Industries’ multiple sclerosis drug Copaxone Teva Pharmaceutical Industries But J.P. Morgan’s Chris Schott warns that there are no quick fixes […]